Approvals (Drugs@FDA)

METRONIDAZOLE

AUROBINDO PHARMA LTD · METRONIDAZOLE

ANDA218485Generic (ANDA)Prescription
Open FDA's page for this record
Application number
ANDA218485
Sponsor name
AUROBINDO PHARMA LTD
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20260925
    Review priority
    STANDARD
    Submission class code
    UNKNOWN
Products
  1. Product number
    001
    Reference drug
    No
    Brand name
    METRONIDAZOLE
    Reference standard
    No
    Dosage form
    GEL
    Route
    VAGINAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      METRONIDAZOLE
      Strength
      0.75%
Harmonized identifiers (openFDA)
Application number
ANDA218485
Brand name
METRONIDAZOLE VAGINAL GEL
Generic name
METRONIDAZOLE
Manufacturer name
Aurobindo Pharma Limited
Product NDC
59651-703
Product type
HUMAN PRESCRIPTION DRUG
Route
VAGINAL
Substance name
METRONIDAZOLE
RxCUI
142046
SPL ID
2ced2460-a003-4314-897b-f4ae0ff72edf
SPL set ID
2ced2460-a003-4314-897b-f4ae0ff72edf
Package NDC
59651-703-70
Nui
N0000175435, M0014907
Pharm class epc
Nitroimidazole Antimicrobial [EPC]
Pharm class cs
Nitroimidazoles [CS]
UNII
140QMO216E
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.